非局部扩散磁共振纤维束密度生物标志物用于胶质母细胞瘤生存分层、预测与解读
该研究提出病变-纤维束密度指数(L-TDI),基于规范性模型量化与肿瘤交互的白质通路,在两个独立队列(N=367和N=496)中验证其可稳健分层生存率,并解释肿瘤体积、白质密度和位置的影响。L-TDI通过Cox模型验证,预测12个月死亡的平衡准确率在训练/测试队列分别为68%和65%,AUC为0.74和0.73。
要点
- L-TDI可稳健分层胶质母细胞瘤患者生存率。
- L-TDI隐含考虑肿瘤体积、白质密度和位置。
- L-TDI预测12个月死亡平衡准确率68%和65%。
核心结论
- L-TDI作为基于白质纤维束密度的生物标志物,可分层、预测和解读胶质母细胞瘤生存率,支持将GBM视为网络疾病。
研究设计与样本
- 研究设计:使用规范性模型设计、分析、解释和测试L-TDI标记,在两个独立队列中验证,样本量分别为N=367和N=496。
主要发现
- 白质图内的纤维束密度可稳健分层生存率。
- L-TDI隐含考虑肿瘤体积、白质密度和位置,解释GBM形态、位置和演化。
- GBM非均匀分布和差异预后源于白质形态。
- L-TDI通过多个Cox生存模型验证,并分析其与其他协变量(如MGMT启动子甲基化)的关系。
- 简单逻辑模型预测12个月死亡,训练和测试在独立队列中平衡准确率分别为68%和65%,AUC分别为0.74和0.73。
关键数值与推荐
- L-TDI标记基于与肿瘤交互的分布式白质通路计算。
- 预测12个月死亡的平衡准确率:训练队列68%,测试队列65%;AUC:训练队列0.74,测试队列0.73。
临床怎么用
- L-TDI可用于胶质母细胞瘤患者生存分层和12个月死亡风险预测,辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma (GBM) is a lethal tumor, actively growing and invading neighboring neural tissue. GBMs appear functionally connected to distributed and spatially distant regions rather than representing an isolated and passive lesion disrupting the brain circuitry. Moreover, increasing evidence suggests that white matter serves as the morphological substrate for GBM to progress and migrate to distant areas in the human brain. METHODS: We hypothesized that the subset of white matter tracts intersecting the tumors depicts the physical substrate for large-scale neuron-glioma interactions and would therefore inform prognosis. Using normative models, we design, analyze, interpret, and test a Lesion-Tract Density Index (L -TDI) marker that considers the distributed white matter pathways interacting with the tumor in 2 independent cohorts of N=367 and N=496 patients, respectively. RESULTS: First, we show that the tract density within this white matter map robustly stratifies survival rates due to widespread white matter involvement. Second, we demonstrate why tract density-based markers offer critical and necessary insights into the morphology, location, and evolution of human GBM by proving how the proposed L -TDI implicitly considers tumor volume, white matter density, and location. We provide further evidence that the non-uniform distribution of GBMs and their differential prognosis emerge from white matter morphology. Third, we validate the L -TDI marker with multiple Cox survival models and analyze its contribution in relation to other covariates of interest (eg, MGMT promoter methylation). Lastly, by using a simple logistic model, we predict patient death at 12 months with balanced accuracies of 68% and 65%, and areas under the curve of 0.74 and 0.73 when training and testing in separate and independent cohorts. CONCLUSIONS: Overall, we offer a concrete implementation of the emerging paradigm that views GBM not as a focal lesion, but as a network disease sh aped by its complex interactions with distant brain regions.
引用
- Falcó-Roget J, Basile GA, Janus A, et al. A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma. Neuro Oncol. 2026. PMID: 41099361. doi:10.1093/neuonc/noaf234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。